Breast Cancer in Young Women about 87 Cases in the General Surgery Department CHU Gabriel Touré
2022; Scientific Research Publishing; Volume: 13; Issue: 11 Linguagem: Inglês
10.4236/ss.2022.1311059
ISSN2157-9415
AutoresMaïga Amadou, Saye Zakari, Sidibé Boubacar Yoro, Diakité Ibrahima, Bah Amadou, Diallo Mahamadou, Diallo Aly Boubacar, Traoré Bathio, Moussa Diassana, Koné Tani, Doumbia Arouna Adama, Traoré Amadou, Mamadou Diallo, Traoré Djibril, Konaté Moussa, Saadé Oumou Hélène, Kanté Lassana, Konaté Madiassa, Dembélé Souleymane, Samaké Moussa, Keita Mory, Dembélé Bakary Tientigui, Traoré Alhassane, Togo Pierre Adégné,
Tópico(s)Cancer Risks and Factors
ResumoOur objectives were to determine the frequency of breast cancer in young women, to determine the risk factors for breast cancer in young women, to detail the diagnostic process of the disease, to determine the different therapeutic strategies. This was a retrospective and descriptive study going from January 2005 to December 2021, a period of 17 years. The study involved 87 women with an average age of 33.2 years. Patients consulted 66 times or 75.9% for breast mass. The size of the tumor was greater than or equal to 5 cm in 62 patients; it was localized in the supero external quadrant 41 times or 47.1%. Molecular classification revealed the following results: Luminal A 21.4%; receptive (HER2) positive 28.6%, and triple negative 42.9%. Stage II was the most represented with 47.4%. Histology found infiltrating carcinoma of non-specific type in 76 patients. The treatment was mastectomy axillary dissection in 66 patients, quadrantectomy + axillary dissection in 6 cases (6.9%) associated with radiotherapy in 6 patients, chemotherapy was performed in 79 of our patients and hormone therapy in 10 patients. Conclusion: Breast cancer is frequent in our country. Patients generally consult us at a late stage. The possibility of determining certain receptors and carrying out certain non-surgical treatments on site would improve the prognosis.
Referência(s)